Zimmer Biomet Holdings - 17 Year Stock Price History | ZBH

Historical daily share price chart and data for Zimmer Biomet Holdings since 2001 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Zimmer Biomet Holdings as of November 19, 2018 is 113.50.
Zimmer Biomet Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 118.2679 123.5189 131.4700 104.9536 113.5000 -5.53%
2017 117.4787 102.0666 131.4927 102.0666 120.1437 17.86%
2016 111.6921 99.7143 130.9103 89.7928 101.9382 1.45%
2015 105.9881 109.3574 118.2641 90.3145 100.4782 -8.79%
2014 98.0203 88.8329 111.5317 87.5135 110.1636 22.75%
2013 76.9536 64.5539 89.9789 64.5539 89.7478 41.20%
2012 59.4417 50.8652 65.4273 50.1768 63.5623 26.18%
2011 54.7857 51.8365 65.7174 44.7074 50.3749 -0.48%
2010 51.8195 56.5986 60.0783 44.2925 50.6200 -9.19%
2009 43.3152 39.3795 56.9004 30.2985 55.7405 46.24%
2008 61.4464 62.5112 75.0908 32.9389 38.1159 -38.90%
2007 76.2101 72.7050 86.6331 59.8614 62.3792 -15.60%
2006 63.5419 64.5764 74.1761 50.0259 73.9120 16.22%
2005 71.8179 74.8550 82.4179 57.9943 63.5957 -15.83%
2004 73.8863 66.0097 84.0681 64.0294 75.5529 13.81%
2003 47.7972 38.0027 67.1130 35.9847 66.3869 69.56%
2002 33.7810 28.5068 40.1716 27.6958 39.1532 35.95%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.927B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.463B 18.51
Abbott Laboratories (ABT) United States $121.292B 24.58
Stryker (SYK) United States $62.096B 23.41
Boston Scientific (BSX) United States $47.118B 23.81
Baxter (BAX) United States $34.153B 22.06
Smith & Nephew SNATS (SNN) United Kingdom $15.749B 0.00
ResMed (RMD) United States $14.479B 27.61
Perrigo (PRGO) Ireland $8.210B 12.46
Bio-Rad Laboratories (BIO) United States $7.933B 50.72
Canopy Growth (CGC) Canada $7.466B 0.00
Hill-Rom Holdings (HRC) United States $6.097B 19.08
Aurora Cannabis (ACB) Canada $5.815B 31.74
Haemonetics (HAE) United States $5.279B 46.42
ICU Medical (ICUI) United States $4.777B 26.62
Insulet (PODD) United States $4.449B 0.00
Hutchison China MediTech (HCM) China $4.244B 0.00
Agios Pharmaceuticals (AGIO) United States $3.828B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.656B 0.00
Neogen (NEOG) United States $3.174B 48.06
NuVasive (NUVA) United States $3.162B 29.43
National Vision Holdings (EYE) United States $2.783B 53.82
Quidel (QDEL) United States $2.312B 30.14
Aphria (APHA) $2.200B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.381B 19.54
AtriCure (ATRC) United States $1.208B 0.00
Cardiovascular Systems (CSII) United States $1.049B 1511.50
VAREX IMAGING (VREX) United States $0.923B 18.53
OraSure Technologies (OSUR) United States $0.783B 44.10
Meridian Bioscience (VIVO) United States $0.780B 24.86
Surmodics (SRDX) United States $0.738B 112.75
PetIQ (PETQ) United States $0.733B 20.83
Cerus (CERS) United States $0.710B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.709B 22.76
MacroGenics (MGNX) United States $0.706B 0.00
Omeros (OMER) United States $0.632B 0.00
Lantheus Holdings (LNTH) United States $0.616B 19.06
LeMaitre Vascular (LMAT) United States $0.533B 26.19
Owens & Minor (OMI) United States $0.525B 5.94
NanoString Technologies (NSTG) United States $0.506B 0.00
Insys Therapeutics (INSY) United States $0.480B 0.00
TG Therapeutics (TGTX) United States $0.405B 0.00
Evolus (EOLS) United States $0.378B 0.00
Quanterix (QTRX) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.344B 22.27
Cytosorbents (CTSO) United States $0.309B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.248B 0.00
Surface Oncology (SURF) United States $0.227B 0.00
Rockwell Medical (RMTI) United States $0.199B 0.00
Bovie Medical (BVX) United States $0.195B 0.00
BioLife Solutions (BLFS) United States $0.193B 261.25
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.137B 6.90
Conatus Pharmaceuticals (CNAT) United States $0.135B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.113B 0.00
Chembio Diagnostics (CEMI) United States $0.104B 0.00
United-Guardian (UG) United States $0.079B 16.64
Female Health (VERU) United States $0.073B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 19.53
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00